Jenny Sundqvist, InDex Pharmaceuticals CEO (website)
June 1, 2023 02:52 PM EDT
Pharma

Vi­a­tris tar­gets ul­cer­a­tive col­i­tis in Japan with $10M agree­ment with Swedish phar­ma In­Dex

Katherine Lewin

News Reporter

Vi­a­tris is go­ing af­ter the ul­cer­a­tive col­i­tis mar­ket in Japan, ink­ing a li­cens­ing agree­ment with Swe­den’s In­Dex Phar­ma­ceu­ti­cals to reg­is­ter and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

The End­points 100: The biotech in­dus­try braces for Trump 2.0

Lil­ly’s oral SERD makes strides in breast can­cer with Phase 3 da­ta

Dur­ing Covid, RFK Jr. lob­bied against vac­cine EUAs for chil­dren. As HHS sec­re­tary, he could re­scind them

Drugs are ap­proved — and made avail­able — faster in US than most of EU, da­ta show

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times